01 Jul 2020
Autolus are a biotech company based in White City in London and they have a presence at the Bioscience Catalyst in Stevenage. It is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London in 2014.
Since its inception, the company has undergone rapid growth, systematically adding the capabilities needed to manufacture and develop its programmed T cell product candidates.
Oval Medical Technologies, a drug delivery device design and development company, specialising in patient-centric auto injectors, have joined as SIP Cambridge members. We are looking forward to them helping us to drive the local skills agenda in Cambridge and the wider South East.
Oval’s CEO, Barbara Lead, recently had an article published in Parliamentary Review, discussing the needs of our industry and how our education system in schools needs to change to encourage more students to study STEM courses. This can be found here.